Sysmex Corp ADR (SSMXY) 37.4000 $SSMXY Sysmex I
Post# of 273254
Posted On: 09/25/2016 11:15:11 AM
Sysmex Corp ADR (SSMXY) 37.4000 $SSMXY
Sysmex Inostics Announces Key Clinical Data to be Presented at ASCO Annual Meeting 2016 - Abstract will be Included in the Best of ASCO® Program
PR Newswire Europe - Wed May 25, 8:02AM CDT
CHICAGO, May 25, 2016 /PRNewswire/ --
Blood-based IVD RAS Biomarker Test Now Available in France
PR Newswire Europe - Wed May 18, 1:01AM CDT
NANCY, France, May 18, 2016 /PRNewswire/ --
BRIC Clinical Chemistry Market Outlook to 2021
M2 - Wed Jan 20, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/2x6jj7/bric_clinical) has announced the addition of the "BRIC Clinical Chemistry Market Outlook to 2021" report to their offering. "BRIC Clinical Chemistry Market Outlook to 2021", provides key market data on the BRIC Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the BRIC Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, BRIC 4 Clinical Chemistry Market, Brazil 5 Clinical Chemistry Market, Russia 6 Clinical Chemistry Market, India 7 Clinical Chemistry Market, China 8 Overview of Key Companies in BRIC Clinical Chemistry Market 9 Clinical Chemistry Market Pipeline Products 10 Appendix Companies Featured - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Danaher Corporation - Abbott Laboratories - Ortho-Clinical Diagnostics Inc. - Transasia Bio-Medicals Ltd. - Agappe Diagnostics Ltd. - Bio-Rad Laboratories, Inc. - Span Diagnostics Ltd. - Sysmex Corporation - Mindray Medical Ic For more information visit http://www.researchandmarkets.com/research/2x...c_clinical
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
BRIC Haematology Market Outlook to 2021
M2 - Tue Jan 19, 10:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lfvn3k/bric_haematology) has announced the addition of the "BRIC Haematology Market Outlook to 2021" report to their offering. "BRIC Haematology Market Outlook to 2021", provides key market data on the BRIC Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the BRIC Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Haematology Market, BRIC 4 Haematology Market, Brazil 5 Haematology Market, Russia 6 Haematology Market, India 7 Haematology Market, China 8 Overview of Key Companies in BRIC Haematology Market 9 Haematology Market Pipeline Products 10 Appendix Companies featured - Siemens Healthcare - Sysmex Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Horiba, Ltd. - Transasia Bio-Medicals Ltd. - Mindray Medical International Limited - Trivitron Healthcare Pvt Ltd. - Bio-Rad Laboratories, Inc. - bioMerieux S.A. For more information visit http://www.researchandmarkets.com/research/lf...aematology
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08), MR: 27.94 (+0.07)
BRIC Histology And Cytology Market Outlook to 2021- Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators
M2 - Tue Jan 19, 9:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/l6f6f4/bric_histology) has announced the addition of the "BRIC Histology And Cytology Market Outlook to 2021" report to their offering. "BRIC Histology And Cytology Market Outlook to 2021", provides key market data on the BRIC Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Histology and Cytology market. - Global corporate-level profiles of key companies operating within the BRIC Histology and Cytology market. - Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Histology And Cytology Market, BRIC 4 Histology And Cytology Market, Brazil 5 Histology And Cytology Market, Russia 6 Histology And Cytology Market, India 7 Histology And Cytology Market, China 8 Overview of Key Companies in BRIC Histology And Cytology Market 9 Histology And Cytology Market Pipeline Products 10 Appendix Companies Mentioned - Becton, Dickinson and Company - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Danaher Corporation - bioMerieux S.A. - Immucor, Inc. - Sysmex Corporation - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/l6..._histology
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Point of Care (POC) Urinalysis Testing Market 2014-2019 Featuring Roche Diagnostics, Siemens Healthcare & Sysmex
M2 - Tue Jan 19, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/db33gh/poc_urinalysis) has announced the addition of the "POC Urinalysis Testing Market" report to their offering. Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: - Selected Dipstick Urinalysis Systems, 2014 - Global POC Urine Strip Testing Market Analysis: 2012-2019 - POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 - POC Urine Test Strip Professional Testing Market Analysis, 2014 and 2019 - Global POC Urine Strip Testing Market Revenues and Market Share of Leading Suppliers, 2014 Some point of care (POC) tests are manual tests, often performed with technologies based on dipsticks or strips. Among the tests on the traditional menu for POC testing is urine strips testing. A sample type that has been used for many years is urine. Today, urine specimens are important for certain types of IVD testing. Urinalysis can be performed to detect certain metabolic disorders, kidney disease, bladder cancer, urinary tract infections, and certain other conditions. Urinalysis or the study of urine samples is already widespread and dipstick urinalysis is the highest volume POC test in the world. Urine is also a commonly used type of specimen for drugs of abuse testing. Large and small companies are involved in the development and/or marketing of POC urine testing. Among the top and/or innovative competitors discussed within Corporate Profiles are: - Roche Diagnostics - Siemens Healthcare - Sysmex Key Topics Covered: ONE: EXECUTIVE SUMMARY - Overview of POC Testing - POC Urine Testing - Size of the Market - POC Professional Testing - POC Self-Testing - Growth of the Market - Leading Competitors TWO: POC URINE STRIP TESTING - Products - Market Size and Growth - POC Urine Strip Self-Testing - POC Urine Test Strip Professional Testing - Competitive Analysis - Product Innovation THREE: POC SUBSTANCE ABUSE TESTING, URINALYSIS - Overview of Substance Abuse Testing - Urine Testing - Drugs of Abuse Testing: Market Size and Growth - Product Innovation FOUR: CORPORATE PROFILES - 77 Elektronika - ACON Laboratories, Inc - Alere Inc - Arkray - Eiken Chemical Co Ltd. - Henry Schein - IRIS International, Inc. - Macherey-Nagel GmbH & Co. KG - McKesson Corporation - Opko Health, Inc - Polymedco, Inc - Quidel Corporation - Radiometer Medical ApS - Roche Diagnostics Corporation - Siemens Healthcare - Stanbio Laboratory - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/db...urinalysis
MCK: 167.08 (-1.04), OPK: 11.09 (+0.23), ALR: 43.24 (-0.43), HSIC: 164.45 (-2.83)
EU5 Clinical Chemistry Market Outlook to 2021
M2 - Fri Jan 15, 7:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/ns6xbw/eu5_clinical) has announced the addition of the "EU5 Clinical Chemistry Market Outlook to 2021" report to their offering. "EU5 Clinical Chemistry Market Outlook to 2021", provides key market data on the EU5 Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the EU5 Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, EU5 4 Clinical Chemistry Market, France 5 Clinical Chemistry Market, Germany 6 Clinical Chemistry Market, Italy 7 Clinical Chemistry Market, Spain 8 Clinical Chemistry Market, United Kingdom 9 Overview of Key Companies in EU5 Clinical Chemistry Market 10 Clinical Chemistry Market Pipeline Products 11 Recent Developments 12 Appendix Companies Mentioned - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Danaher Corporation - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation - ELITech Group - Mindray Medical International Limited For more information visit http://www.researchandmarkets.com/research/ns...5_clinical
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08), MR: 27.94 (+0.07)
EU5 Haematology Market Outlook to 2021 - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology
M2 - Fri Jan 15, 5:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/xvqppw/eu5_haematology) has announced the addition of the "EU5 Haematology Market Outlook to 2021" report to their offering. "EU5 Haematology Market Outlook to 2021", provides key market data on the EU5 Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the EU5 Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Haematology Market, EU5 4 Haematology Market, France 5 Haematology Market, Germany 6 Haematology Market, Italy 7 Haematology Market, Spain 8 Haematology Market, United Kingdom 9 Overview of Key Companies in EU5 Haematology Market 10 Haematology Market Pipeline Products 11 Recent Developments 12 Appendix Companies Mentioned - Siemens Healthcare - Sysmex Corporation - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Abbott Laboratories - Diagnostica Stago, Inc. For more information visit http://www.researchandmarkets.com/research/xv...aematology
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Global Urine Analysis Pipeline Review, 2015 - Analysis, Technologies & Forecasts
M2 - Wed Dec 23, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/6ghm37/urine_analysis) has announced the addition of the "Urine Analysis - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products. Key Topics Covered: - Extensive coverage of the Urine Analysis products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Urine Analysis products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage Benefits of this Report: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Urine Analysis products under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline Companies Mentioned: - Analyticon Biotechnologies AG - Arkray, Inc. - Biosense Technologies Pvt Ltd. - California Pacific Medical Center Research Institute - Erba Diagnostics, Inc. - Imagnus Biomedical Inc. - Imperial College London - IRIS International, Inc. - LifeAssays AB - Roche Diagnostics International Ltd. - Scanadu HQ - Shenzhen Genius Electronics Co., Ltd. - Siemens Healthcare Diagnostics Inc. - Stanford University - Svenska Cellulosa Aktiebolaget - Sysmex Corporation - Teco Diagnostics - University of California, San Francisco - University of Kentucky - University of Maryland, Baltimore Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Products under Development 4 Urine Analysis - Pipeline Products under Development by Companies 5 Urine Analysis Companies and Product Overview 6 Urine Analysis- Recent Developments 7 Appendix For more information visit http://www.researchandmarkets.com/research/6g...e_analysis
Australia Haematology Market Outlook to 2021 - Analysis, Technologies & Forecasts
M2 - Tue Dec 22, 5:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/h98lcl/australia) has announced the addition of the "Australia Haematology Market Outlook to 2021" report to their offering. The new report, "Australia Haematology Market Outlook to 2021", provides key market data on the Australia Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. Key Topics Covered: - Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the Australia Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - Sysmex Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - Abbott Laboratories - bioMerieux S.A. - Bio-Rad Laboratories, Inc. - Diagnostica Stago, Inc. - Grifols, S.A. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Haematology Market, Australia 4 Overview of Key Companies in Australia, Haematology Market 5 Haematology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/h98lcl/australia
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Australia Clinical Chemistry Market Report - Analysis, Trends, Technologies & Outlook 2015-2021
M2 - Fri Dec 18, 10:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/9sjqbv/australia) has announced the addition of the "Australia Clinical Chemistry Market Outlook to 2021" report to their offering. Our new report, "Australia Clinical Chemistry Market Outlook to 2021", provides key market data on the Australia Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. Key Topics Covered: - Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the Australia Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - bioMerieux S.A. - Abbott Laboratories - Danaher Corporation - Bio-Rad Laboratories, Inc. - Sysmex Corporation Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Clinical Chemistry Market, Australia 4 Overview of Key Companies in Australia, Clinical Chemistry Market 5 Clinical Chemistry Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/9sjqbv/australia
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
US Haematology Market Report - Analysis, Trends, Technologies & Outlook 2015-2021
M2 - Fri Dec 18, 9:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/nrdn63/united_states) has announced the addition of the "United States Haematology Market Outlook to 2021" report to their offering. Our new report, "United States Haematology Market Outlook to 2021", provides key market data on the United States Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. Key Topics Covered: - Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the United States Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - Danaher Corporation - Sysmex Corporation - Bio-Rad Laboratories, Inc. - F. Hoffmann-La Roche Ltd. - Immucor, Inc. - Abbott Laboratories - bioMerieux S.A. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Haematology Market, United States 4 Overview of Key Companies in United States, Haematology Market 5 Haematology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/nr...ted_states
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
US Histology & Cytology Market Report - Analysis, Trends, Technologies & Outlook 2015-2021
M2 - Fri Dec 18, 9:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/r9nx8j/united_states) has announced the addition of the "United States Histology and Cytology Market Outlook to 2021" report to their offering. Our new report, "United States Histology and Cytology Market Outlook to 2021", provides key market data on the United States Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. Key Topics Covered: - Histology and Cytology market includes Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Histology and Cytology market. - Global corporate-level profiles of key companies operating within the United States Histology and Cytology market. - Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Becton, Dickinson and Company - F. Hoffmann-La Roche Ltd. - Danaher Corporation - Immucor, Inc. - Thermo Fisher Scientific Inc. - Abbott Laboratories - Sysmex Corporation Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Histology and Cytology Market, United States 4 Overview of Key Companies in United States, Histology and Cytology Market 5 Histology and Cytology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/r9...ted_states
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Global IVD Procedure Volumes and Pricing Analysis Report - Profiles Include Siemens, Roche & Gen-Probe, Inc
M2 - Mon Dec 14, 7:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/mpftmx/ivd_procedure) has announced the addition of the "IVD Procedure Volumes and Pricing Analysis" report to their offering. This Kalorama Information report, IVD Procedure Volumes and Pricing Analysis, takes an informative look at worldwide procedure volumes for IVD tests. The report provides global 2014 sales of equipment, reagents and other products related to in vitro diagnostic tests. Market estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include: - Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other) - Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other) - HematologyCoagulation (PT, PTT) - Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media) - Blood BankingCore lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune) - Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs) This report, IVD Procedure Volumes and Pricing Analysis is a one of a kind reprot that demonstrates to readers which companies are performing what share of IVD procedures in the market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report: - Roche - Siemens - Spectra Laboratories - Sysmex Corp. - Thermo Fisher Scientific - Abbott Laboratories - ALERE - ArkrayBeckman Coulter, Inc. - Danaher - Becton - Dickinson & Co. - bioMerieux, Inc - Bio-RAD Laboratories, Inc - Bio-Reference Laboratories - Genoptix, Inc. - Novartis - Gen-Probe, Inc - Hologic, Inc - Horiba Medical - Instrumentation Laboratory - Laboratory Corporation of America - Myriad Genetics - Ortho Clinical Diagnostics - Qiagen - Quest Diagnostics - Radiometer A/S - Clarient, Inc. - GE Healthcare - Danaher Corp - DaVita, Inc. Report Structure: ONE: EXECUTIVE SUMMARY TWO: INTRODUCTION THREE: POINT-OF-CARE TESTS FOUR: CORE LABORATORY TESTS FIVE: MOLECULAR ASSAYS SIX: HEMATOLOGY SEVEN: COAGULATION EIGHT: MICROBIOLOGY NINE: TESTS USED IN BLOOD BANKING TEN: HISTOLOGY AND CYTOLOGY ELEVEN: PROFILES OF KEY PLAYERS APPENDIX: COMPANY DIRECTORY For more information visit http://www.researchandmarkets.com/research/mp..._procedure
ABT: 42.19 (-0.03), MYGN: 21.67 (+0.17), DHR: 77.59 (-0.08), DVA: 66.50 (-0.22), DGX: 85.44 (-0.29), HOLX: 38.45 (-0.33), NVS: 81.48 (-0.55)
European Enzyme Immunoassay (EIA) Market Report - Analysis, Technologies & Forecast 2015-2020
M2 - Mon Dec 14, 5:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/gdv4fs/european_enzyme) has announced the addition of the "European Enzyme Immunoassay (EIA) Market By Type, By Technique, By End User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics, Blood Banks) Analysis and Forecast to 2020" report to their offering. The report analyzes the European enzyme immunoassay (EIA) Market by type, technique, end-user, and by country. The European enzyme immunoassay (EIA) market has been classified on the basis of types which mainly includes; EIA reagents & kits, and EIA analyzers. On the basis of technique the market is divided into; ELISA, rapid tests, and ELISPOT. In-depth Market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, Annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Companies Mentioned: - Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter (Subsidiary Of Danaher Corporation) - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc. - Biom?rieux Sa - Diasorin S.P.A. - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division Of F. Hoffmann-La Roche Ltd.) - Siemens Healthcare (Subsidiary Of Siemens Ag) - Sysmex Corporation Report Structure: 1. Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Europe Enzyme Immunoassay (EIA) Market, Type/Technique 6 Europe Enzyme Immunoassay (EIA) Market, By End-User 7 Europe Enzyme Immunoassay (EIA) Market, By Geography 8 Europe Enzyme Immunoassay (EIA) Market: Competitive Landscape 9 Europe Enzyme Immuno Assay (EIA) Market, By Company 10 Appendix For more information visit http://www.researchandmarkets.com/research/gd...ean_enzyme
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08), ALR: 43.24 (-0.43)
Cell Surface Markers Identification - Global Strategic Business Report 2015-2020 - Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth
M2 - Fri Dec 11, 6:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/ctnc8s/cell_surface) has announced the addition of the "Cell Surface Markers Identification - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets: Research, and Diagnosis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 79 companies including many key and niche players such as - Abbott Laboratories (US) - BD Biosciences (US) - Beckman Coulter, Inc. (US) - Bio-Rad Laboratories, Inc. (US) - CellaVision AB (Sweden) - Dako Denmark A/S (Denmark) - eBioscience, Inc. (US) - EMD Millipore (US) - F. Hoffmann-La Roche Ltd. (Switzerland) - Grifols, S.A (Spain) - Horiba Ltd. (Japan) - Mindray Medical International Limited (China) - Ortho-Clinical Diagnostics, Inc. (US) - QIAGEN N.V. (The Netherlands) - Siemens Healthcare (Germany) - Sysmex Corporation (Japan) - Thermo Fisher Scientific, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. NOTEWORTHY MARKET TRENDS & GROWTH DRIVERS 3. COMPETITION 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/LAUNCHES 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 79 (including Divisions/Subsidiaries - 105) - The United States (47) - Canada (1) - Japan (
- Europe (30) - - France (4) - - Germany ( - - The United Kingdom (5) - - Italy (1) - - Spain (2) - - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (18) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/ct...ll_surface
ABT: 42.19 (-0.03), QGEN: 26.66 (-0.21), MR: 27.94 (+0.07)
North America Histology And Cytology Market Report - Analysis, Technologies & Forecasts 2015-2021
M2 - Fri Dec 11, 2:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztbfjz/north_america) has announced the addition of the "North America Histology And Cytology Market Outlook to 2021" report to their offering. This new report, "North America Histology And Cytology Market Outlook to 2021", provides key market data on the North America Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: - Histology and Cytology market includes Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Histology and Cytology market. - Global corporate-level profiles of key companies operating within the North America Histology and Cytology market. - Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Becton, Dickinson and Company - Immucor, Inc. - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Sysmex Corporation - Thermo Fisher Scientific Inc. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Histology And Cytology Market, North America 4 Histology And Cytology Market, Canada 5 Histology And Cytology Market, Mexico 6 Histology And Cytology Market, United States 7 Overview of Key Companies in North America Histology And Cytology Market 8 Histology And Cytology Market Pipeline Products 9 Recent Developments 10 Appendix For more information visit http://www.researchandmarkets.com/research/zt...th_america
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
United States In Vitro Diagnostics (IVD) Market Report - Analysis, Trends, Technologies & Forecast 2015-2021
M2 - Fri Dec 11, 2:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/sc2nzh/united_states_in) has announced the addition of the "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture" report to their offering. This new report, "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the United States In Vitro Diagnostics market. Key Topics Covered: - In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for In Vitro Diagnostics market. - Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics market. - Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Danaher Corporation - Abbott Laboratories - Becton, Dickinson and Company - Hologic, Inc. - bioMerieux S.A. - Qiagen N.V. - Bio-Rad Laboratories, Inc. - Alere Inc. - Thermo Fisher Scientific Inc. - Immucor, Inc. - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation - Cepheid - PerkinElmer, Inc. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 In Vitro Diagnostics Market, United States 4 Clinical Chemistry Market, United States 5 Genetic Testing Market, United States 6 Haematology Market, United States 7 Histology And Cytology Market, United States 8 Immuno Chemistry Market, United States 9 Infectious Diagnostics Market, United States 10 Microbiology Culture Market, United States 11 Overview of Key Companies in United States, In Vitro Diagnostics Market 12 In Vitro Diagnostics Market Pipeline Products 13 Financial Deals Landscape 14 Appendix For more information visit http://www.researchandmarkets.com/research/sc..._states_in
ABT: 42.19 (-0.03), CPHD: 52.50 (unch), QGEN: 26.66 (-0.21), DHR: 77.59 (-0.08), ALR: 43.24 (-0.43), PKI: 55.53 (-0.08), HOLX: 38.45 (-0.33)
Sysmex Inostics Announces Key Clinical Data to be Presented at ASCO Annual Meeting 2016 - Abstract will be Included in the Best of ASCO® Program
PR Newswire Europe - Wed May 25, 8:02AM CDT
CHICAGO, May 25, 2016 /PRNewswire/ --
Blood-based IVD RAS Biomarker Test Now Available in France
PR Newswire Europe - Wed May 18, 1:01AM CDT
NANCY, France, May 18, 2016 /PRNewswire/ --
BRIC Clinical Chemistry Market Outlook to 2021
M2 - Wed Jan 20, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/2x6jj7/bric_clinical) has announced the addition of the "BRIC Clinical Chemistry Market Outlook to 2021" report to their offering. "BRIC Clinical Chemistry Market Outlook to 2021", provides key market data on the BRIC Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the BRIC Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, BRIC 4 Clinical Chemistry Market, Brazil 5 Clinical Chemistry Market, Russia 6 Clinical Chemistry Market, India 7 Clinical Chemistry Market, China 8 Overview of Key Companies in BRIC Clinical Chemistry Market 9 Clinical Chemistry Market Pipeline Products 10 Appendix Companies Featured - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Danaher Corporation - Abbott Laboratories - Ortho-Clinical Diagnostics Inc. - Transasia Bio-Medicals Ltd. - Agappe Diagnostics Ltd. - Bio-Rad Laboratories, Inc. - Span Diagnostics Ltd. - Sysmex Corporation - Mindray Medical Ic For more information visit http://www.researchandmarkets.com/research/2x...c_clinical
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
BRIC Haematology Market Outlook to 2021
M2 - Tue Jan 19, 10:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lfvn3k/bric_haematology) has announced the addition of the "BRIC Haematology Market Outlook to 2021" report to their offering. "BRIC Haematology Market Outlook to 2021", provides key market data on the BRIC Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the BRIC Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Haematology Market, BRIC 4 Haematology Market, Brazil 5 Haematology Market, Russia 6 Haematology Market, India 7 Haematology Market, China 8 Overview of Key Companies in BRIC Haematology Market 9 Haematology Market Pipeline Products 10 Appendix Companies featured - Siemens Healthcare - Sysmex Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Horiba, Ltd. - Transasia Bio-Medicals Ltd. - Mindray Medical International Limited - Trivitron Healthcare Pvt Ltd. - Bio-Rad Laboratories, Inc. - bioMerieux S.A. For more information visit http://www.researchandmarkets.com/research/lf...aematology
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08), MR: 27.94 (+0.07)
BRIC Histology And Cytology Market Outlook to 2021- Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators
M2 - Tue Jan 19, 9:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/l6f6f4/bric_histology) has announced the addition of the "BRIC Histology And Cytology Market Outlook to 2021" report to their offering. "BRIC Histology And Cytology Market Outlook to 2021", provides key market data on the BRIC Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Histology and Cytology market. - Global corporate-level profiles of key companies operating within the BRIC Histology and Cytology market. - Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Histology And Cytology Market, BRIC 4 Histology And Cytology Market, Brazil 5 Histology And Cytology Market, Russia 6 Histology And Cytology Market, India 7 Histology And Cytology Market, China 8 Overview of Key Companies in BRIC Histology And Cytology Market 9 Histology And Cytology Market Pipeline Products 10 Appendix Companies Mentioned - Becton, Dickinson and Company - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Danaher Corporation - bioMerieux S.A. - Immucor, Inc. - Sysmex Corporation - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/l6..._histology
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Point of Care (POC) Urinalysis Testing Market 2014-2019 Featuring Roche Diagnostics, Siemens Healthcare & Sysmex
M2 - Tue Jan 19, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/db33gh/poc_urinalysis) has announced the addition of the "POC Urinalysis Testing Market" report to their offering. Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: - Selected Dipstick Urinalysis Systems, 2014 - Global POC Urine Strip Testing Market Analysis: 2012-2019 - POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 - POC Urine Test Strip Professional Testing Market Analysis, 2014 and 2019 - Global POC Urine Strip Testing Market Revenues and Market Share of Leading Suppliers, 2014 Some point of care (POC) tests are manual tests, often performed with technologies based on dipsticks or strips. Among the tests on the traditional menu for POC testing is urine strips testing. A sample type that has been used for many years is urine. Today, urine specimens are important for certain types of IVD testing. Urinalysis can be performed to detect certain metabolic disorders, kidney disease, bladder cancer, urinary tract infections, and certain other conditions. Urinalysis or the study of urine samples is already widespread and dipstick urinalysis is the highest volume POC test in the world. Urine is also a commonly used type of specimen for drugs of abuse testing. Large and small companies are involved in the development and/or marketing of POC urine testing. Among the top and/or innovative competitors discussed within Corporate Profiles are: - Roche Diagnostics - Siemens Healthcare - Sysmex Key Topics Covered: ONE: EXECUTIVE SUMMARY - Overview of POC Testing - POC Urine Testing - Size of the Market - POC Professional Testing - POC Self-Testing - Growth of the Market - Leading Competitors TWO: POC URINE STRIP TESTING - Products - Market Size and Growth - POC Urine Strip Self-Testing - POC Urine Test Strip Professional Testing - Competitive Analysis - Product Innovation THREE: POC SUBSTANCE ABUSE TESTING, URINALYSIS - Overview of Substance Abuse Testing - Urine Testing - Drugs of Abuse Testing: Market Size and Growth - Product Innovation FOUR: CORPORATE PROFILES - 77 Elektronika - ACON Laboratories, Inc - Alere Inc - Arkray - Eiken Chemical Co Ltd. - Henry Schein - IRIS International, Inc. - Macherey-Nagel GmbH & Co. KG - McKesson Corporation - Opko Health, Inc - Polymedco, Inc - Quidel Corporation - Radiometer Medical ApS - Roche Diagnostics Corporation - Siemens Healthcare - Stanbio Laboratory - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/db...urinalysis
MCK: 167.08 (-1.04), OPK: 11.09 (+0.23), ALR: 43.24 (-0.43), HSIC: 164.45 (-2.83)
EU5 Clinical Chemistry Market Outlook to 2021
M2 - Fri Jan 15, 7:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/ns6xbw/eu5_clinical) has announced the addition of the "EU5 Clinical Chemistry Market Outlook to 2021" report to their offering. "EU5 Clinical Chemistry Market Outlook to 2021", provides key market data on the EU5 Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the EU5 Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Chemistry Market, EU5 4 Clinical Chemistry Market, France 5 Clinical Chemistry Market, Germany 6 Clinical Chemistry Market, Italy 7 Clinical Chemistry Market, Spain 8 Clinical Chemistry Market, United Kingdom 9 Overview of Key Companies in EU5 Clinical Chemistry Market 10 Clinical Chemistry Market Pipeline Products 11 Recent Developments 12 Appendix Companies Mentioned - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Danaher Corporation - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation - ELITech Group - Mindray Medical International Limited For more information visit http://www.researchandmarkets.com/research/ns...5_clinical
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08), MR: 27.94 (+0.07)
EU5 Haematology Market Outlook to 2021 - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology
M2 - Fri Jan 15, 5:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/xvqppw/eu5_haematology) has announced the addition of the "EU5 Haematology Market Outlook to 2021" report to their offering. "EU5 Haematology Market Outlook to 2021", provides key market data on the EU5 Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Scope - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the EU5 Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Haematology Market, EU5 4 Haematology Market, France 5 Haematology Market, Germany 6 Haematology Market, Italy 7 Haematology Market, Spain 8 Haematology Market, United Kingdom 9 Overview of Key Companies in EU5 Haematology Market 10 Haematology Market Pipeline Products 11 Recent Developments 12 Appendix Companies Mentioned - Siemens Healthcare - Sysmex Corporation - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Abbott Laboratories - Diagnostica Stago, Inc. For more information visit http://www.researchandmarkets.com/research/xv...aematology
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Global Urine Analysis Pipeline Review, 2015 - Analysis, Technologies & Forecasts
M2 - Wed Dec 23, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/6ghm37/urine_analysis) has announced the addition of the "Urine Analysis - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products. Key Topics Covered: - Extensive coverage of the Urine Analysis products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Urine Analysis products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage Benefits of this Report: - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Urine Analysis products under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline Companies Mentioned: - Analyticon Biotechnologies AG - Arkray, Inc. - Biosense Technologies Pvt Ltd. - California Pacific Medical Center Research Institute - Erba Diagnostics, Inc. - Imagnus Biomedical Inc. - Imperial College London - IRIS International, Inc. - LifeAssays AB - Roche Diagnostics International Ltd. - Scanadu HQ - Shenzhen Genius Electronics Co., Ltd. - Siemens Healthcare Diagnostics Inc. - Stanford University - Svenska Cellulosa Aktiebolaget - Sysmex Corporation - Teco Diagnostics - University of California, San Francisco - University of Kentucky - University of Maryland, Baltimore Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Products under Development 4 Urine Analysis - Pipeline Products under Development by Companies 5 Urine Analysis Companies and Product Overview 6 Urine Analysis- Recent Developments 7 Appendix For more information visit http://www.researchandmarkets.com/research/6g...e_analysis
Australia Haematology Market Outlook to 2021 - Analysis, Technologies & Forecasts
M2 - Tue Dec 22, 5:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/h98lcl/australia) has announced the addition of the "Australia Haematology Market Outlook to 2021" report to their offering. The new report, "Australia Haematology Market Outlook to 2021", provides key market data on the Australia Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. Key Topics Covered: - Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the Australia Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - Sysmex Corporation - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - Abbott Laboratories - bioMerieux S.A. - Bio-Rad Laboratories, Inc. - Diagnostica Stago, Inc. - Grifols, S.A. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Haematology Market, Australia 4 Overview of Key Companies in Australia, Haematology Market 5 Haematology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/h98lcl/australia
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Australia Clinical Chemistry Market Report - Analysis, Trends, Technologies & Outlook 2015-2021
M2 - Fri Dec 18, 10:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/9sjqbv/australia) has announced the addition of the "Australia Clinical Chemistry Market Outlook to 2021" report to their offering. Our new report, "Australia Clinical Chemistry Market Outlook to 2021", provides key market data on the Australia Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. Key Topics Covered: - Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Clinical Chemistry market. - Global corporate-level profiles of key companies operating within the Australia Clinical Chemistry market. - Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - bioMerieux S.A. - Abbott Laboratories - Danaher Corporation - Bio-Rad Laboratories, Inc. - Sysmex Corporation Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Clinical Chemistry Market, Australia 4 Overview of Key Companies in Australia, Clinical Chemistry Market 5 Clinical Chemistry Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/9sjqbv/australia
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
US Haematology Market Report - Analysis, Trends, Technologies & Outlook 2015-2021
M2 - Fri Dec 18, 9:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/nrdn63/united_states) has announced the addition of the "United States Haematology Market Outlook to 2021" report to their offering. Our new report, "United States Haematology Market Outlook to 2021", provides key market data on the United States Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. Key Topics Covered: - Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Haematology market. - Global corporate-level profiles of key companies operating within the United States Haematology market. - Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A.. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - Danaher Corporation - Sysmex Corporation - Bio-Rad Laboratories, Inc. - F. Hoffmann-La Roche Ltd. - Immucor, Inc. - Abbott Laboratories - bioMerieux S.A. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Haematology Market, United States 4 Overview of Key Companies in United States, Haematology Market 5 Haematology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/nr...ted_states
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
US Histology & Cytology Market Report - Analysis, Trends, Technologies & Outlook 2015-2021
M2 - Fri Dec 18, 9:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/r9nx8j/united_states) has announced the addition of the "United States Histology and Cytology Market Outlook to 2021" report to their offering. Our new report, "United States Histology and Cytology Market Outlook to 2021", provides key market data on the United States Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. Key Topics Covered: - Histology and Cytology market includes Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Histology and Cytology market. - Global corporate-level profiles of key companies operating within the United States Histology and Cytology market. - Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Becton, Dickinson and Company - F. Hoffmann-La Roche Ltd. - Danaher Corporation - Immucor, Inc. - Thermo Fisher Scientific Inc. - Abbott Laboratories - Sysmex Corporation Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Histology and Cytology Market, United States 4 Overview of Key Companies in United States, Histology and Cytology Market 5 Histology and Cytology Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/r9...ted_states
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
Global IVD Procedure Volumes and Pricing Analysis Report - Profiles Include Siemens, Roche & Gen-Probe, Inc
M2 - Mon Dec 14, 7:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/mpftmx/ivd_procedure) has announced the addition of the "IVD Procedure Volumes and Pricing Analysis" report to their offering. This Kalorama Information report, IVD Procedure Volumes and Pricing Analysis, takes an informative look at worldwide procedure volumes for IVD tests. The report provides global 2014 sales of equipment, reagents and other products related to in vitro diagnostic tests. Market estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include: - Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other) - Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other) - HematologyCoagulation (PT, PTT) - Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media) - Blood BankingCore lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune) - Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs) This report, IVD Procedure Volumes and Pricing Analysis is a one of a kind reprot that demonstrates to readers which companies are performing what share of IVD procedures in the market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report: - Roche - Siemens - Spectra Laboratories - Sysmex Corp. - Thermo Fisher Scientific - Abbott Laboratories - ALERE - ArkrayBeckman Coulter, Inc. - Danaher - Becton - Dickinson & Co. - bioMerieux, Inc - Bio-RAD Laboratories, Inc - Bio-Reference Laboratories - Genoptix, Inc. - Novartis - Gen-Probe, Inc - Hologic, Inc - Horiba Medical - Instrumentation Laboratory - Laboratory Corporation of America - Myriad Genetics - Ortho Clinical Diagnostics - Qiagen - Quest Diagnostics - Radiometer A/S - Clarient, Inc. - GE Healthcare - Danaher Corp - DaVita, Inc. Report Structure: ONE: EXECUTIVE SUMMARY TWO: INTRODUCTION THREE: POINT-OF-CARE TESTS FOUR: CORE LABORATORY TESTS FIVE: MOLECULAR ASSAYS SIX: HEMATOLOGY SEVEN: COAGULATION EIGHT: MICROBIOLOGY NINE: TESTS USED IN BLOOD BANKING TEN: HISTOLOGY AND CYTOLOGY ELEVEN: PROFILES OF KEY PLAYERS APPENDIX: COMPANY DIRECTORY For more information visit http://www.researchandmarkets.com/research/mp..._procedure
ABT: 42.19 (-0.03), MYGN: 21.67 (+0.17), DHR: 77.59 (-0.08), DVA: 66.50 (-0.22), DGX: 85.44 (-0.29), HOLX: 38.45 (-0.33), NVS: 81.48 (-0.55)
European Enzyme Immunoassay (EIA) Market Report - Analysis, Technologies & Forecast 2015-2020
M2 - Mon Dec 14, 5:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/gdv4fs/european_enzyme) has announced the addition of the "European Enzyme Immunoassay (EIA) Market By Type, By Technique, By End User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics, Blood Banks) Analysis and Forecast to 2020" report to their offering. The report analyzes the European enzyme immunoassay (EIA) Market by type, technique, end-user, and by country. The European enzyme immunoassay (EIA) market has been classified on the basis of types which mainly includes; EIA reagents & kits, and EIA analyzers. On the basis of technique the market is divided into; ELISA, rapid tests, and ELISPOT. In-depth Market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, Annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Companies Mentioned: - Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter (Subsidiary Of Danaher Corporation) - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc. - Biom?rieux Sa - Diasorin S.P.A. - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division Of F. Hoffmann-La Roche Ltd.) - Siemens Healthcare (Subsidiary Of Siemens Ag) - Sysmex Corporation Report Structure: 1. Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Europe Enzyme Immunoassay (EIA) Market, Type/Technique 6 Europe Enzyme Immunoassay (EIA) Market, By End-User 7 Europe Enzyme Immunoassay (EIA) Market, By Geography 8 Europe Enzyme Immunoassay (EIA) Market: Competitive Landscape 9 Europe Enzyme Immuno Assay (EIA) Market, By Company 10 Appendix For more information visit http://www.researchandmarkets.com/research/gd...ean_enzyme
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08), ALR: 43.24 (-0.43)
Cell Surface Markers Identification - Global Strategic Business Report 2015-2020 - Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth
M2 - Fri Dec 11, 6:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/ctnc8s/cell_surface) has announced the addition of the "Cell Surface Markers Identification - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Cell Surface Markers Identification in US$ Million by the following Product Segments: Flow Cytometers, and Others. The Global market is further analyzed by the following Application Markets: Research, and Diagnosis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 79 companies including many key and niche players such as - Abbott Laboratories (US) - BD Biosciences (US) - Beckman Coulter, Inc. (US) - Bio-Rad Laboratories, Inc. (US) - CellaVision AB (Sweden) - Dako Denmark A/S (Denmark) - eBioscience, Inc. (US) - EMD Millipore (US) - F. Hoffmann-La Roche Ltd. (Switzerland) - Grifols, S.A (Spain) - Horiba Ltd. (Japan) - Mindray Medical International Limited (China) - Ortho-Clinical Diagnostics, Inc. (US) - QIAGEN N.V. (The Netherlands) - Siemens Healthcare (Germany) - Sysmex Corporation (Japan) - Thermo Fisher Scientific, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. NOTEWORTHY MARKET TRENDS & GROWTH DRIVERS 3. COMPETITION 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/LAUNCHES 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 79 (including Divisions/Subsidiaries - 105) - The United States (47) - Canada (1) - Japan (
- Europe (30) - - France (4) - - Germany ( - - The United Kingdom (5) - - Italy (1) - - Spain (2) - - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (18) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/ct...ll_surface ABT: 42.19 (-0.03), QGEN: 26.66 (-0.21), MR: 27.94 (+0.07)
North America Histology And Cytology Market Report - Analysis, Technologies & Forecasts 2015-2021
M2 - Fri Dec 11, 2:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztbfjz/north_america) has announced the addition of the "North America Histology And Cytology Market Outlook to 2021" report to their offering. This new report, "North America Histology And Cytology Market Outlook to 2021", provides key market data on the North America Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: - Histology and Cytology market includes Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Histology and Cytology market. - Global corporate-level profiles of key companies operating within the North America Histology and Cytology market. - Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Becton, Dickinson and Company - Immucor, Inc. - Danaher Corporation - F. Hoffmann-La Roche Ltd. - Abbott Laboratories - Sysmex Corporation - Thermo Fisher Scientific Inc. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Histology And Cytology Market, North America 4 Histology And Cytology Market, Canada 5 Histology And Cytology Market, Mexico 6 Histology And Cytology Market, United States 7 Overview of Key Companies in North America Histology And Cytology Market 8 Histology And Cytology Market Pipeline Products 9 Recent Developments 10 Appendix For more information visit http://www.researchandmarkets.com/research/zt...th_america
ABT: 42.19 (-0.03), DHR: 77.59 (-0.08)
United States In Vitro Diagnostics (IVD) Market Report - Analysis, Trends, Technologies & Forecast 2015-2021
M2 - Fri Dec 11, 2:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/sc2nzh/united_states_in) has announced the addition of the "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture" report to their offering. This new report, "United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the United States In Vitro Diagnostics market. Key Topics Covered: - In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing. - Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for In Vitro Diagnostics market. - Global corporate-level profiles of key companies operating within the United States In Vitro Diagnostics market. - Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others. Benefits of this Report: - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Siemens Healthcare - F. Hoffmann-La Roche Ltd. - Danaher Corporation - Abbott Laboratories - Becton, Dickinson and Company - Hologic, Inc. - bioMerieux S.A. - Qiagen N.V. - Bio-Rad Laboratories, Inc. - Alere Inc. - Thermo Fisher Scientific Inc. - Immucor, Inc. - Ortho-Clinical Diagnostics Inc. - Sysmex Corporation - Cepheid - PerkinElmer, Inc. Report Structure: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 In Vitro Diagnostics Market, United States 4 Clinical Chemistry Market, United States 5 Genetic Testing Market, United States 6 Haematology Market, United States 7 Histology And Cytology Market, United States 8 Immuno Chemistry Market, United States 9 Infectious Diagnostics Market, United States 10 Microbiology Culture Market, United States 11 Overview of Key Companies in United States, In Vitro Diagnostics Market 12 In Vitro Diagnostics Market Pipeline Products 13 Financial Deals Landscape 14 Appendix For more information visit http://www.researchandmarkets.com/research/sc..._states_in
ABT: 42.19 (-0.03), CPHD: 52.50 (unch), QGEN: 26.66 (-0.21), DHR: 77.59 (-0.08), ALR: 43.24 (-0.43), PKI: 55.53 (-0.08), HOLX: 38.45 (-0.33)
(0)
(0)Scroll down for more posts ▼